Access Bio, Inc. (KOSDAQ: 950130)

Access Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	191,375	302,841	414,360	569,632	784,363	67,553
Market Cap Growth	-16.04%	-26.91%	-27.26%	-27.38%	1061.10%	-41.16%
Enterprise Value	-101,716	-43,387	-123,881	568,975	809,032	100,782
Last Close Price	5660.00	8970.00	12200.00	14944.24	20595.03	1924.07
PE Ratio	-	-	1.32	2.91	14.80	-
Forward PE	-	22.67	22.67	22.67	22.67	22.67
PS Ratio	1.92	0.87	0.40	1.13	6.44	1.57
PB Ratio	0.31	0.52	0.66	1.96	9.05	2.42
P/TBV Ratio	0.36	0.52	0.67	1.99	9.44	3.12
P/FCF Ratio	-	-	1.18	4.40	31.06	-
P/OCF Ratio	-	-	1.12	3.48	22.01	-
EV/Sales Ratio	-	-	-	1.13	6.64	2.34
EV/EBITDA Ratio	-	-	-	2.14	11.57	-
EV/EBIT Ratio	-	-	-	2.19	12.16	-
EV/FCF Ratio	0.98	-	-	4.40	32.03	-
Debt / Equity Ratio	0.12	0.12	0.12	0.24	0.55	1.37
Debt / EBITDA Ratio	-	1.93	0.16	0.26	0.68	-
Debt / FCF Ratio	-	-	0.22	0.54	1.87	-
Asset Turnover	0.14	0.44	1.56	1.65	1.02	0.52
Inventory Turnover	2.05	2.44	2.54	2.65	1.73	3.33
Quick Ratio	9.85	8.37	3.01	1.85	1.13	0.75
Current Ratio	11.32	9.51	3.65	2.37	1.61	1.46
Return on Equity (ROE)	-2.80%	-0.87%	76.35%	100.91%	83.46%	-57.93%
Return on Assets (ROA)	-3.11%	1.74%	44.09%	53.02%	34.67%	-9.42%
Return on Capital (ROIC)	-3.26%	2.01%	55.13%	65.70%	41.59%	-10.14%
Earnings Yield	-8.03%	-1.05%	83.66%	33.30%	6.15%	-26.04%
FCF Yield	-53.97%	-40.45%	84.57%	22.72%	3.22%	-5.14%
Buyback Yield / Dilution	-0.24%	10.73%	-1.46%	-7.75%	-21.66%	-8.29%
Total Shareholder Return	-0.24%	10.73%	-1.46%	-7.75%	-21.66%	-8.29%

Source: S&P Capital IQ. Standard template. Financial Sources.